受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder | |
化学式 | C31H26N2O3 |
|||
分子量 | 474.55 | CAS No. | 300657-03-8 | |
Solubility (25°C)* | 体外 | DMSO | 95 mg/mL (200.18 mM) | |
Ethanol | 18 mg/mL (37.93 mM) | |||
Water | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | BMS309403 is a small-molecule FABP4 inhibitor with nM affinity (Kd=4 nM for FABP4) and >100-fold selectivity against FABP5 as well as the heart isoform FABP3. |
---|---|
in vitro | Treatment of BMS309403 (FABP4 inhibitor) comobined with SSO (CD36 inhibitor) significantly decreases the breast cancer cell viability, proliferative, migratory, and invasive abilities over 72 h. Inhibiting either at recommended concentrations does not significantly decrease the breast cancer cell viability over 72 h. Treatment with both SSO and BMS309403 results in clustering of cells and increased lipid content, indicating an inability to metabolise lipids resulting potentially in lipotoxicity-induced apoptosis.[1] |
in vivo | Treatment with either BMS309403 or SSO alone decreases the rate of tumour formation and the combination of BMS309403 and SSO significantly decreased the rate of tumour formation. |
細胞アッセイ | 細胞株 | Humen breast cancer cell lines |
---|---|---|
濃度 | 20 μM | |
反応時間 | 72 h | |
実験の流れ | Cell viability after CD36 knockout or treatment with SSO and BMS-309403 is determined by seeding 2500 cells in 96-well plate, and cultured for 24 h, after which treatment agent is added at appropriate concentration and maintained for 72 h. Cell viabilities is evaluated at 6, 12, 24, 36, 48, 60 and 72 h using the EZ-CYTOX cell viability kit. |
|
動物実験 | 動物モデル | Nude mice bearing MDA-MB-231 xenograft tumors |
投薬量 | 15 mg/kg | |
投与方法 | o.g. |
|
Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis [ Cell Death Dis, 2022, 13(4):333] | PubMed: 35410456 |
FABP4-mediated lipid droplet formation in Streptococcus uberis-infected macrophages supports host defence [ Vet Res, 2022, 53(1):90] | PubMed: 36371263 |
Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer [ NPJ Breast Cancer, 2021, 7(1):129] | PubMed: 34561446 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。